Copyright
©The Author(s) 2021.
World J Gastroenterol. Jul 28, 2021; 27(28): 4653-4666
Published online Jul 28, 2021. doi: 10.3748/wjg.v27.i28.4653
Published online Jul 28, 2021. doi: 10.3748/wjg.v27.i28.4653
SNP ID (rs number) | Chromosome location (GRCh38) | Cancer type | Model | Region | Effect | MAF | OR (95%CI) | P value | Ref. |
rs689465A>G | 1:186681714 | Gastric | G/A | Promoter | Significant interaction with H. pylori infection | 0.143 | 0.84 (0.57-1.24) | 0.381 | Zhang et al[55] |
rs689466G>A | 1:186681619 | Gastric | A/G | Promoter | Increases transcriptional activity by creating a c-MYB binding site | 0.176 | 1.19 (1.10-1.29) | 0.002a | Li et al[14], Piranda et al[16], Zhang et al[55], Lopes et al[56], Liu et al[57], Shin et al[58], Guo et al[59], Zamudio et al[60], and Luo et al[61] |
rs20417G>C | 1:186681189 | Gastric | C/G | Promoter | Reduces promoter activity by creating a binding site for NPM and P-NPM | 0.109 | 1.26 (1.12-1.41) | < 0.001a | Li et al[14], Piranda et al[16], Liu et al[17], Zhang et al[55], Shin et al[58], Sitarz et al[62], Saxena et al[63], Hou et al[64], Zhang et al[65], Campanholo et al[66], He et al[67], and Di Marco et al[68] |
rs3218625G>A | 1:186674409 | Gastric | A/G | Promoter | Enhances activity of COX-2 in vitro by causing the transition of Gly to Aly | < 0.001 | 1.62 (1.02-2.56) | 0.039a | Zhang et al[55] and Zhang et al[65] |
rs5277G>C | 1:186679065 | Gastric | GC/GG | Exon | - | 0.108 | 0.42 (0.13-1.28) | 0.127 | Hussain et al[69] |
rs5278T>C | 1:186676537 | Gastric | TC/TT | Exon | - | 0.021 | 2.27 (0.53-9.69) | 0.270 | Hussain et al[69] |
rs5279T>C | 1:186675946 | Gastric | TC/TT | Exon | - | 0.015 | 0.24 (0.08-0.73) | 0.012a | Hussain et al[69] |
rs2745557G>A | 1:186680089 | Pancreatic | A/G | Intron | - | 0.164 | 0.94 (0.64-1.39) | 0.764 | Özhan et al[70] |
rs2066826G>A | 1:186676795 | Pancreatic | A/G | Intron | - | 0.188 | 1.60 (1.06-2.40) | 0.026a | Özhan et al[70] |
rs4648262G>T | 1:186679617 | Pancreatic | T/G | Intron | - | < 0.001 | 0.62 (0.22-1.73) | 0.364 | Özhan et al[70] |
rs4648298A>G | 1:186672550 | Colorectal | G/A | 3′-UTR | Creates a longer and possibly more stable species of mRNA | 0.021 | 0.44 (0.25-0.75) | 0.003a | Gholami et al[71], Mosallaei et al[72], and Cox et al[73] |
rs5275T>C | 1:186673926 | Gastric | C/T | 3′-UTR | Stabilizes mRNA of COX-2 by potential miRNA-binding sites | 0.351 | 1.14 (1.01-1.29) | 0.030a | Piranda et al[16], Li et al[74], and Furuya et al[75] |
rs689470T>C | 1:186671926 | Gastric | TC/TT | 3′-UTR | Degradation of the mRNA | 0.039 | 7.49 (1.21-46.20) | 0.030a | Hussain et al[69] and Hu et al[76] |
rs2206593A>G | 1:186673297 | Breast | G/A | 3′-UTR | - | 0.060 | 0.92 (0.84-1.91) | 0.088 | Li et al[77] |
- Citation: Ji XK, Madhurapantula SV, He G, Wang KY, Song CH, Zhang JY, Wang KJ. Genetic variant of cyclooxygenase-2 in gastric cancer: More inflammation and susceptibility. World J Gastroenterol 2021; 27(28): 4653-4666
- URL: https://www.wjgnet.com/1007-9327/full/v27/i28/4653.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i28.4653